The newest Biobanking in Finland & Personalized Medicine magazine has now been published.
In the magazine, our experts explain why Finland is the ideal country to conduct biobank and real-world evidence (RWE) research. The article also summarizes briefly the results of our recent biobank report.
The magazine itself gives a comprehensive picture of biobanks and biobank research.
Read the digital version of the whole magazine here. You can find our article from the pages 22-23.
The conference explores how real-world data (RWD) and artificial intelligence (AI) can transform drug development, regulatory and HTA decision-making, and ultimately drive value-based, patient-focused healthcare.
Medaffcon develops the Patient Dynamics tool based on customer feedback and user experience.
Patient Dynamics tool compiles up-to-date and regional data on medicine use in Finland and Sweden.